Despite election uncertainty, the stock market has remained robust, with the S&P 500 surging 20% year-to-date, making it the most bullish election-year market in decades. Morgan Stanley analysts have identified two stocks, Tenaya Therapeutics and Royalty Pharma, poised for substantial growth regardless of the election outcome, with potential upside as high as 670% and 88%, respectively.